1,2-dioxetanes: novel chemiluminescent enzyme substrates. Applications to immunoassays.

Journal of Bioluminescence and Chemiluminescence
I BronsteinJ C Voyta

Abstract

We have synthesized and studied two 1,2-dioxetane-based chemiluminescent enzyme substrates: 3-(2'-spiroadamantane)-4-methoxy-4-(3"-phosphoryloxy)phenyl- 1,2-dioxetane (AMPPD), and, 3-(2'-spiroadamantane)-4-methoxy-4-(3"-beta-D'-galactopyrano -yloxy)phenyl-1,2- dioxetane (AMPGD), which can be activated to chemiluminescence at 470 nm by alkaline phosphatase and beta-D-galactosidase, respectively. In addition, we observed that certain macromolecules enhance the luminescence of AMPPD. For example, the addition of 0.1% bovine serum albumin amplifies the luminescent signal and improves the detection limit for alkaline phosphatase by approximately one order of magnitude under certain conditions. This effect is due to the presence of a hydrophobic microenvironment provided by the enhancer which 'stabilizes' the dephosphorylated AMPPD emitter. Alkaline phosphatase catalysed chemiluminescence from AMPPD is constant for a prolonged period of time. Using AMPPD we were able to detect 0.01 attomole quantities of alkaline phosphatase immobilized on membrane supports and imaged on photographic film and, in solution, measured in a luminometer. AMPPD and AMPGD offer alternatives to colorimetric and fluorescent substrates for alkaline phosphatase...Continue Reading

References

Jan 1, 1986·Methods in Enzymology·J C HummelenH Wynberg
Jan 1, 1986·Methods in Enzymology·A ThompsonG H Posner

❮ Previous
Next ❯

Citations

Jun 1, 1994·Molecular Biotechnology·U ReischlC Kessler
Jun 1, 1994·Molecular Biotechnology·D Egger, K Bienz
Feb 28, 2006·Analytical and Bioanalytical Chemistry·M A González-MartínezR Puchades
Dec 17, 1990·Clinica Chimica Acta; International Journal of Clinical Chemistry·E IshikawaK Hirota
Dec 17, 1990·Clinica Chimica Acta; International Journal of Clinical Chemistry·N C Nelson, D L Kacian
Apr 8, 1991·Journal of Immunological Methods·E Roffman, N Frenkel
Oct 16, 1996·Journal of Immunological Methods·H A RongenW P van Bennekom
Jun 30, 1994·Journal of Biotechnology·C Kessler
Apr 1, 1994·Journal of Pharmaceutical and Biomedical Analysis·H A RongenW P van Bennekom
Feb 1, 1991·Current Opinion in Biotechnology·T T Ngo
Mar 1, 1995·Genetic Analysis : Biomolecular Engineering·C L SmithU J Krull
Dec 14, 1999·Journal of Immunological Methods·M BachyE Trannoy
Jan 27, 1999·Journal of Pharmaceutical and Biomedical Analysis·P PasiniA Roda
Jul 1, 1996·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·M ShinbaraT Orii
Feb 13, 2001·The British Journal of Dermatology·M T LinK Yoon
Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P G Gillespie, A J Hudspeth
Oct 29, 1996·Proceedings of the National Academy of Sciences of the United States of America·W A Mohler, H M Blau
Feb 1, 1994·Journal of Immunoassay·G Kominami
Apr 20, 2004·Assay and Drug Development Technologies·Michael WeberPriya Kunapuli
May 1, 1992·The Plant Cell·E P FontesL Hanley-Bowdoin
Nov 8, 2011·Bioscience, Biotechnology, and Biochemistry·Satoshi SekiguchiKuniyo Inouye
May 10, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Julien Bôle, Stéphane Mabic
Apr 23, 2011·Bioscience, Biotechnology, and Biochemistry·Satoshi SekiguchiKuniyo Inouye
Aug 12, 2014·Biological & Pharmaceutical Bulletin·Tadanobu TakahashiTakashi Suzuki
Jul 1, 1995·Journal of Bioluminescence and Chemiluminescence·L LamarcqE Brambilla
Jun 30, 2011·Expert Opinion on Drug Discovery·Juan M Bustamante, Rick L Tarleton
Jun 18, 2011·Luminescence : the Journal of Biological and Chemical Luminescence·Larry J Kricka, Philip E Stanley
Apr 25, 2014·Luminescence : the Journal of Biological and Chemical Luminescence·Jason Y ParkRalph P Mason
May 9, 2000·American Journal of Clinical Pathology·J L Bock
Jun 24, 2015·Journal of Biomedical Science·Jen-Chieh Tseng, Andrew L Kung

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.